22nd Century Group (NASDAQ:XXII) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the biotechnology company’s stock.

22nd Century Group Price Performance

Shares of NASDAQ XXII opened at $0.09 on Tuesday. 22nd Century Group has a 52-week low of $0.08 and a 52-week high of $5.28. The company has a debt-to-equity ratio of 1.59, a quick ratio of 0.93 and a current ratio of 1.09. The stock has a 50 day moving average price of $0.16 and a 200 day moving average price of $0.58. The firm has a market capitalization of $4.36 million, a price-to-earnings ratio of 0.00 and a beta of 1.45.

22nd Century Group (NASDAQ:XXII) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The business had revenue of $5.95 million for the quarter.

Institutional Trading of 22nd Century Group

A hedge fund recently raised its stake in 22nd Century Group stock. Anson Funds Management LP boosted its holdings in shares of 22nd Century Group, Inc. (NASDAQ:XXII) by 106.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,577,814 shares of the biotechnology company’s stock after buying an additional 3,399,323 shares during the quarter. Anson Funds Management LP owned 83.28% of 22nd Century Group worth $789,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 18.06% of the company’s stock.

About 22nd Century Group

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.